SPATA7 anticorps (C-Term)
Aperçu rapide pour SPATA7 anticorps (C-Term) (ABIN954913)
Antigène
Voir toutes SPATA7 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 341-369, C-Term
-
Specificité
- This antibody recognizes SPATA7 / HSD3 at C-term.
-
Réactivité croisée (Details)
- Species reactivity (tested):Human
-
Purification
- Purified through a Protein A column followed by peptide affinity purification
-
Immunogène
- Synthetic peptide - KLH conjugated - corresponding to the C-terminal region (between 341-369aa) of human SPATA7 / HSD3
-
Isotype
- Ig Fraction
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.25 mg/mL
-
Buffer
- PBS with 0.09 % (W/V) Sodium azide
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Avoid repeated freezing and thawing.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- SPATA7 (Spermatogenesis Associated 7 (SPATA7))
-
Autre désignation
- SPATA7 / HSD3
-
Sujet
- The SPATA7 gene, originally isolated from testis, is also expressed in retina. Mutations in this gene are associated with Leber's congenital amaurosis (LCA) and juvenile retinitis pigmentosa. Alternatively spliced transcript variants encoding different isoforms have been found for this gene.Synonyms: HSD-3.1, Spermatogenesis-associated protein 7
-
ID gène
- 55812
-
NCBI Accession
- NP_001035518
Antigène
-